---
$id: https://graph.org.ai/products/commodity/51201823
$type: Product
source: UNSPSC
code: "51201823"
title: "Molgramostim"
class: "51201800"
classTitle: "Immunostimulating agents"
family: "51200000"
familyTitle: "Immunomodulating drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Molgramostim

**UNSPSC Code**: 51201823
**Class**: [Immunostimulating agents](Immunostimulating agents.mdx)
**Family**: [Immunomodulating drugs](../Immunomodulating drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a therapeutic granulocyte-macrophage colony-stimulating factor with the molecular formula C639H1007N171O196S8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B321AL142J, more generally known as molgramostim. European Medicines Agency schedules molgramostim in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09040MIG. The term MOLGRAMOSTIM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, no. 3 1991, list 31. MOLGRAMOSTIM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule Molgramostim under HS 30012090 and SITC 54162. SMILES:. As of Q4 2014, MOLGRAMOSTIM remains the US FDA Preferred Term for this commodity. . Molgramostim bears US NLM identifiers UMLS ID C0218633 and NCI Concept Code C77591.

